Barcelona Liver Bioservices announces presentation at AASLD Meeting about the effects of targeting the LPA pathway in preclinical models of advanced chronic liver disease
Barcelona Liver Bioservices in collaboration with Gilead Sciences, is excited to announce the results of an original study that showcases the potential of targeting the LPA pathway in the treatment of advanced chronic liver disease.